SEC Filings

SEC Filings

Filing date	Description	Form	View
Jan 23, 2013	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001144204-13-003526.pdf 0001144204-13-003526.rtf 0001144204-13-003526.xls
Dec 19, 2012		D	View HTML 0001427570-12-000005.pdf 0001427570-12-000005.rtf 0001427570-12-000005.xls
Nov 13, 2012	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-12-467504.pdf 0001193125-12-467504.rtf 0001193125-12-467504.xls
Nov 08, 2012	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-12-460558.pdf 0001193125-12-460558.rtf 0001193125-12-460558.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Nov 05, 2012	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001144204-12-059462.pdf 0001144204-12-059462.rtf 0001144204-12-059462.xls
Oct 24, 2012	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-12-432288.pdf 0001193125-12-432288.rtf 0001193125-12-432288.xls
Oct 04, 2012	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-12-415578.pdf 0001193125-12-415578.rtf 0001193125-12-415578.xls
Oct 04, 2012	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	View HTML 0001193125-12-415586.pdf 0001193125-12-415586.rtf 0001193125-12-415586.xls
Sep 28, 2012	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-12-409096.pdf 0001193125-12-409096.rtf 0001193125-12-409096.xls
Sep 28, 2012	Securities offered to employees pursuant to employee benefit plans	S-8	View HTML 0001193125-12-409106.pdf 0001193125-12-409106.rtf 0001193125-12-409106.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE